Mark E. Saad - Feb 21, 2025 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Nick Pizzie, Attorney-in-Fact
Stock symbol
AXSM
Transactions as of
Feb 21, 2025
Transactions value $
$0
Form type
4
Date filed
2/25/2025, 07:59 PM
Previous filing
Sep 11, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +1.49K $0.00 1.49K Feb 21, 2025 Common Stock 1.49K $137.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 1,494 options elected to be received in lieu of cash compensation earned in 2024. All of such options are immediately exercisable.